Steven E Finkelstein
Overview
Explore the profile of Steven E Finkelstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
4284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jahraus C, Wallner P, Heron D, Crook W, Finkelstein S, Harris A, et al.
Cureus
. 2024 Nov;
16(11):e74098.
PMID: 39575357
Radiation oncology is among the most data-driven specialties in medicine. Recently, a wealth of peer-reviewed data has been published supporting the treatment of oligometastatic malignancies, demonstrating improved survival with metastasis-directed...
2.
Zumsteg Z, Sheth S, Jabbour S, Patel K, Kimple R, Williams T, et al.
Lancet Oncol
. 2024 Oct;
25(10):e489-e500.
PMID: 39362260
NRG Oncology's Developmental Therapeutics and Radiation Therapy Subcommittee assembled an interdisciplinary group of investigators to address barriers to successful early phase clinical trials of novel combination therapies involving radiation. This...
3.
Luh J, Finkelstein S, Michalski J, Sandler H
Ann Intern Med
. 2018 Apr;
168(8):607-608.
PMID: 29677258
No abstract available.
4.
Okunieff P, Casey-Sawicki K, Lockney N, Hoppe B, Enderling H, Pinnix C, et al.
Clin Cancer Res
. 2018 Apr;
24(15):3500-3509.
PMID: 29661779
The Radiation Therapy Committee of SWOG periodically evaluates its strategic plan in an effort to maintain a current and relevant scientific focus, and to provide a standard platform for future...
5.
Hong J, Rahimy E, Gross C, Shafman T, Hu X, Yu J, et al.
Pract Radiat Oncol
. 2017 Sep;
8(3):e79-e86.
PMID: 28888675
Purpose: Adjuvant radiation therapy (RT) for breast cancer improves outcomes, but prior studies have documented substantive cardiac dose and cardiac risk. We assessed the mean heart dose (MHD) of RT...
6.
Crawford E, Petrylak D, Shore N, Saad F, Slovin S, Vogelzang N, et al.
Urology
. 2017 Mar;
104:150-159.
PMID: 28302580
Objective: To offer recommendations on identification of disease progression, treatment management strategies, and suggestions on timing of initiating and discontinuing specific castration-resistant prostate cancer (CRPC) treatments. Materials And Methods: The...
7.
Crawford E, Albala D, Wysocki J, Lepor H, Ross A, Finkelstein S, et al.
Rev Urol
. 2017 Jan;
18(4):205-213.
PMID: 28127262
No abstract available.
8.
Johnson S, Soulos P, Shafman T, Mantz C, Dosoretz A, Ross R, et al.
Radiother Oncol
. 2016 Nov;
121(2):294-298.
PMID: 27890426
Background And Purpose: Evaluate changes in bowel, urinary and sexual patient-reported quality of life following treatment with moderately hypofractionated radiotherapy (<5Gray/fraction) or stereotactic body radiation therapy (SBRT;5-10Gray/fraction) for prostate cancer....
9.
Stahl J, Ross R, Harder E, Mancini B, Soulos P, Finkelstein S, et al.
Int J Radiat Oncol Biol Phys
. 2016 Nov;
96(5):1011-1020.
PMID: 27869080
Purpose: To determine the effect of biologically effective dose (BED) and radiation treatment schedule on overall survival (OS) in patients with early-stage non-small cell lung cancer (NSCLC) undergoing stereotactic body...
10.
Lee J, Daignault-Newton S, Heath G, Scarlett S, Sanda M, Chang P, et al.
Int J Radiat Oncol Biol Phys
. 2016 Sep;
96(4):770-777.
PMID: 27663760
Purpose: The new short Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) patient-reported health-related quality of life (HRQOL) tool has removed the rectal bleeding question from the previous much...